日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

FDA批准摘要:Blinatumomab用于多阶段化疗巩固期治疗B细胞前体急性淋巴细胞白血病

Rabik, Cara A; Wang, Shu; Chadda, Ritu; Przepiorka, Donna; Vallejo, Jonathon; Jiang, Xiling; Theoret, Marc R; de Claro, R Angelo

Implementation of real-time optimization control to reduce environmental impact in laser diode assisted sustainable leather cutting

在激光二极管辅助可持续皮革切割中应用实时优化控制以减少对环境的影响

Swaminathan, Vasanth; Rabik, M Mohamed; Meligy, Rowida; Chekalil, Ismail

Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia

B细胞急性淋巴细胞白血病患儿、青少年及青年接受Tisagenlecleucel治疗后无应答及复发的预后

Schultz, Liora M; Eaton, Anne; Baggott, Christina; Rossoff, Jenna; Prabhu, Snehit; Keating, Amy K; Krupski, Christa; Pacenta, Holly; Philips, Christine L; Talano, Julie-An; Moskop, Amy; Baumeister, Susanne H C; Myers, Gary Douglas; Karras, Nicole A; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle; Satwani, Prakash; Wilcox, Rachel; Rabik, Cara A; Fabrizio, Vanessa A; Chinnabhandar, Vasant; Kunicki, Michael; Mavroukakis, Sharon; Egeler, Emily; Li, Yimei; Mackall, Crystal L; Curran, Kevin J; Verneris, Michael R; Laetsch, Theodore W; Stefanski, Heather

Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

较高剂量的tisagenlecleucel与更好的治疗效果相关:儿科真实世界CAR联盟的一份报告

Stefanski, Heather E; Eaton, Anne; Baggott, Christina; Rossoff, Jenna; Verneris, Michael R; Prabhu, Snehit; Pacenta, Holly L; Phillips, Christine L; Talano, Julie-An; Moskop, Amy; Margossian, Steven P; Myers, Gary Douglas; Karras, Nicole A; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle; Satwani, Prakash; Krupski, M Christa; Keating, Amy K; Wilcox, Rachel; Rabik, Cara A; Fabrizio, Vanessa A; Chinnabhandar, Vasant; Goksenin, A Yasemin; Curran, Kevin J; Mackall, Crystal L; Laetsch, Theodore W; Schultz, Liora M

[The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries]

[BMI对急性SARS-CoV-2感染病程的影响以及出院后第一年出现的风险。AKTIV和AKTIV 2注册研究的亚组分析证据]

Arutyunov, A G; Tarlovskaya, E I; Galstyan, G R; Batluk, T I; Bashkinov, R A; Arutyunov, G G; Belenkov, Yu N; Konradi, A O; Lopatin, Yu M; Rebrov, A P; Tereshchenko, S N; Chesnikova, A I; Hayrapetyan, H G; Babin, A P; Bakulin, I G; Bakulina, N V; Balykova, L A; Blagonravova, A S; Boldina, M V; Butomo, M I; Vaisberg, A R; Galyavich, A S; Gomonova, V V; Grigoryeva, N Yu; Gubareva, I V; Demko, I V; Evzerikhina, A V; Zharkov, A V; Zateishchikova, A A; Kamilova, U K; Kim, Z F; Kuznetsova, T Yu; Kulikov, A N; Lareva, N A V; Makarova, E V; Malchikova, S V; Nedogoda, S V; Petrova, M M; Pochinka, I G; Protasov, K V; Protsenko, D N; Ruzanov, D Yu; Saiganov, S A; Sarybaev, A Sh; Selezneva, N M; Sugraliev, A B; Fomin, I V; Khlynova, O V; Chizhova, O Yu; Shaposhnik, I I; Schukarev, D A; Abdrakhmanova, A K; Avetisyan, S A; Avoyan, H G; Azaryan, K K; Aimakhanova, G T; Ayypova, D A; Akunov, A Ch; Alieva, M K; Almukhambedova, A R; Aparkina, A V; Aruslanova, O R; Ashina, E Yu; Badina, O Na Yu; Barysheva, O Yu; Batchaeva, A S; Bitieva, A M; Bikhteev, I U; Borodulina, N A; Bragin, M V; Brazhnik, V A; Budu, A M; Bykova, G A; Vagapova, K R; Varlamova, D D; Vezikova, N N; Verbitskaya, E A; Vilkova, O E; Vinnikova, E A; Vustina, V V; Galova, E A; Genkel, V V; Giller, D B; Gorshenina, E I; Grigoryeva, E V; Gubareva, E Yu; Dabylova, G M; Demchenko, A I; Dolgikh, O Yu; Duishobaev, M Y; Evdokimov, D S; Egorova, K E; Ermilova, A N; Zheldybaeva, A E; Zarechnova, N V; Zimina, Yu D; Ivanova, S Yu; Ivanchenko, E Yu; Ilina, M V; Kazakovtseva, M V; Kazymova, E V; Kalinina, Yu S; Kamardina, N A; Karachenova, A M; Karetnikov, I A; Karoli, N A; Karsiev, M Kh; Kaskaeva, D S; Kasymova, K F; Kerimbekova, Zh B; Kim, E S; Kiseleva, N V; Klimenko, D A; Klimova, A V; Kovalishena, O V; Kozlov, S V; Kolmakova, E V; Kolchinskaya, T P; Kolyadich, M I; Kondryakova, O V; Konoval, M P; Konstantinov, D Yu; Konstantinova, E A; Kordyukova, V A; Koroleva, E V; Kraposhina, A Yu; Kryukova, T V; Kuznetsova, A S; Kuzmina, T Yu; Kuzmichev, K V; Kulchoroeva, Ch K; Kuprina, T V; Kuranova, I A M; Kurenkova, L Va V; Kurchugina, N Yu; Kushubakova, N A; Levankova, V I; Ledyaeva, A A; Lisun, T V; Lisyanskaya, V E; Lyubavina, N A; Magdeeva, N A; Mazalov, K V; Mayseenko, V I; Makarova, A S; Maripov, A M; Markov, N V; Marusina, A A; Melnikov, E S; Metlinskaya, A I; Moiseenko, N B; Muradova, F N; Muradyan, R G; Musaelyan, Sh N; Nekaeva, E S; Nikitina, N M; Nifontov, S E; Obolentseva, E Yu; Obukhova, A A; Ogurlieva, B B; Odegova, A A; Omarova, Yu V; Omurzakova, N A; Ospanova, Sh O; Pavlova, V A; Pakhomova, E V Pakhomova; Petrov, L D; Plastinina, S S; Platonov, D A; Pogrebetskaya, V Aya A; Polyakov, D V; Polyakov, D S; Ponomarenko, E Enko V; Popova, L L; Potanin, A A; Prokofieva, N A; Rabik, Yu D; Rakov, N A; Rakhimov, A N; Rozanova, N A; Samus, I V; Serikbolkyzy, S; Sidorkina, Ya A; Simonov, A A; Skachkova, V V; Skvortsova, R D; Skuridin, D S; Solovieva, D V; Solovieva, I A; Sukhomlinova, I M; Sushilova, A G; Tagaeva, D R; Titoykina, Yu V; Tikhonova, E P; Tokmin, D S; Tolmacheva, A A; Torgunakova, M S; Trenogina, K V; Trostyanetskaya, N Aya A; Trofimov, D A; Trubnikova, M A; Tulichev, A A; Tursunova, A T; Ulanova, N D; Fatenkov, O V; Fedorishina, O V; Fil, T S; Fomina, I Yu; Fominova, I S; Frolova, I A; Tsvinger, S M; Tsoma, V V; Cholponbaeva, M B; Chudinovskikh, T Skikh I; Shavrin, I V; Shevchenko, O A; Shikhaliev, D R; Shishkina, E A; Shishkov, K Yu; Shcherbakov, S Yu; Shcherbakova, G V; Yausheva, E A

Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

疾病负担影响儿童和青少年B细胞淋巴母细胞白血病患者接受商业化Tisagenlecleucel治疗后的预后:一项儿科真实世界嵌合抗原受体联盟报告

Schultz, Liora M; Baggott, Christina; Prabhu, Snehit; Pacenta, Holly L; Phillips, Christine L; Rossoff, Jenna; Stefanski, Heather E; Talano, Julie-An; Moskop, Amy; Margossian, Steven P; Verneris, Michael R; Myers, Gary Douglas; Karras, Nicole A; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle; Satwani, Prakash; Krupski, Christa; Keating, Amy K; Wilcox, Rachel; Rabik, Cara A; Fabrizio, Vanessa A; Rouce, Rayne H; Chinnabhandar, Vasant; Kunicki, Michael; Barsan, Valentin V; Goksenin, A Yasemin; Li, Yimei; Mavroukakis, Sharon; Egeler, Emily; Curran, Kevin J; Mackall, Crystal L; Laetsch, Theodore W

Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

tisagenlecleucel 在婴儿急性淋巴细胞白血病中的实际应用

Moskop, Amy; Pommert, Lauren; Baggott, Christina; Prabhu, Snehit; Pacenta, Holly L; Phillips, Christine L; Rossoff, Jenna; Stefanski, Heather E; Talano, Julie-An; Margossian, Steve P; Verneris, Michael R; Myers, G Doug; Karras, Nicole A; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle L; Satwani, Prakash; Krupski, Christa; Keating, Amy K; Wilcox, Rachel; Rabik, Cara A; Fabrizio, Vanessa A; Chinnabhandar, Vasant; Goksenin, A Yasemin; Curran, Kevin J; Mackall, Crystal L; Laetsch, Theodore W; Guest, Erin M; Breese, Erin H; Schultz, Liora M

Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

最佳的氟达拉滨淋巴清除与CAR-T细胞疗法后疗效的改善相关。

Fabrizio, Vanessa A; Boelens, Jaap Jan; Mauguen, Audrey; Baggott, Christina; Prabhu, Snehit; Egeler, Emily; Mavroukakis, Sharon; Pacenta, Holly; Phillips, Christine L; Rossoff, Jenna; Stefanski, Heather E; Talano, Julie-An; Moskop, Amy; Margossian, Steven P; Verneris, Michael R; Myers, Gary Douglas; Karras, Nicole A; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle; Satwani, Prakash; Krupski, Christa; Keating, Amy K; Wilcox, Rachel; Rabik, Cara A; Chinnabhandar, Vasant; Kunicki, Michael; Goksenin, A Yasemin; Mackall, Crystal L; Laetsch, Theodore W; Schultz, Liora M; Curran, Kevin J

Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

Tisagenlecleucel治疗复发/难治性髓外急性淋巴细胞白血病的疗效:儿科真实世界CAR联盟报告

Fabrizio, Vanessa A; Phillips, Christine L; Lane, Adam; Baggott, Christina; Prabhu, Snehit; Egeler, Emily; Mavroukakis, Sharon; Pacenta, Holly; Rossoff, Jenna; Stefanski, Heather E; Talano, Julie-An; Moskop, Amy; Margossian, Steven P; Verneris, Michael R; Myers, Gary Douglas; Karras, Nicole A; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle; Satwani, Prakash; Krupski, Christa; Keating, Amy K; Wilcox, Rachel; Rabik, Cara A; Chinnabhandar, Vasant; Kunicki, Michael; Goksenin, A Yasemin; Curran, Kevin J; Mackall, Crystal L; Laetsch, Theodore W; Schultz, Liora M

Out-of-specification tisagenlecleucel does not compromise safety or efficacy in pediatric acute lymphoblastic leukemia

不符合规格的tisagenlecleucel不会影响儿童急性淋巴细胞白血病的安全性和有效性。

Rossoff, Jenna; Baggott, Christina; Prabhu, Snehit; Pacenta, Holly; Phillips, Christine L; Stefanski, Heather; Talano, Julie-An; Moskop, Amy; Margossian, Steven P; Verneris, Michael R; Myers, Gary Douglas; Karras, Nicole; Brown, Patrick A; Qayed, Muna; Hermiston, Michelle; Satwani, Prakash; Krupski, Christa; Keating, Amy K; Wilcox, Rachel; Rabik, Cara A; Fabrizio, Vanessa A; Kunicki, Michael; Chinnabhandar, Vasant; Goksenin, A Yasemin; Curran, Kevin J; Mackall, Crystal L; Laetsch, Theodore W; Schultz, Liora M